Kazia Therapeutics Ltd ADR (KZIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2020 | 12-2019 | 06-2019 | 12-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,372 | -4,023 | -7,345 | N/A | -4,682 |
| Depreciation Amortization | 728 | 371 | 776 | N/A | 1,199 |
| Other Working Capital | 1,640 | 1,375 | 252 | N/A | 58 |
| Other Operating Activity | 88 | 405 | 1,515 | 0 | -3,290 |
| Operating Cash Flow | $-5,916 | $-1,872 | $-4,802 | $N/A | $-6,715 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | 1,687 | 0 | 116 |
| Investing Cash Flow | $0 | $N/A | $1,687 | $N/A | $116 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 8,152 | 2,557 | 2,729 | 0 | 0 |
| Financing Cash Flow | $8,152 | $2,557 | $2,729 | $N/A | $0 |
| Exchange Rate Effect | 0 | N/A | 12 | N/A | 9 |
| Beginning Cash Position | 3,649 | 3,717 | 4,260 | N/A | 11,207 |
| End Cash Position | 5,885 | 4,402 | 3,886 | N/A | 4,618 |
| Net Cash Flow | $2,236 | $686 | $-374 | $N/A | $-6,589 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,916 | -1,872 | -4,802 | N/A | -6,715 |
| Free Cash Flow | -5,916 | -1,872 | -4,802 | 0 | -6,715 |